Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Gastrointestinal » Inflammatory Bowel Disease 24. October 2026
Search
medline.ch
Inflammatory Bowel Disease
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Gastrointestinal
Diarrhea
Inflammatory Bowel Disease
Functional Diseases
Gastroenteritis
Gastrointestinal Hemorrhage
Neoplasms
Peptic Ulcer
Others
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2960  Previews Next
   
   Articles 1 - 20 / 59189  
   
Chia seed oil attenuates titanium dioxide nanoparticles-induced ulcerative colitis in rats through suppression of NLRP3 inflammasome pathway "Histological and Molecular Study".
J Mol Histol
Sarhan NR, Shrief AI, Elmowafy R, Elekhtiar SA.
PMID: 42919997 [PubMed - indexed for MEDLINE]


Latent profile analysis of fertility motivation in women with inflammatory bowel disease: a cross-sectional study.
BMC Womens Health
Wang Y, Chen Y, Dong Q, Gao X, Jiang B.
PMID: 42919338 [PubMed - indexed for MEDLINE]


[New data on appendectomies for ulcerative colitis].
MMW Fortschr Med
Gross M.
PMID: 42919070 [PubMed - in process]


Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics-a practical guide for clinicians.
J Crohns Colitis
Con D, Li Wai Suen C, Choy M, Flegg JA, De Cruz P.
PMID: 42918627 [PubMed - indexed for MEDLINE]


Exploration of international differences in preoperative characteristics, indications, postoperative management and endoscopic recurrence rates in patients with Crohn's disease following ileocolic (re-)resection: first outcomes from the IMPACT consortium.
J Crohns Colitis
Bak MTJ, Hammoudi N, Lee SH, Maggiori L, van Ruler O, Bezault M, Hernandez-Rocha C, de Vries AC, Silverberg MS, Allez M, IMPACT (International Multidisciplinary Research Collaboration on Postoperative IBD) consortium; on behalf of the Dutch Initiative on Crohn and Colitis and the RAP-CD study group; on behalf of the NIDDK Inflammatory Bowel Disease Genetics Consortium; on behalf of the REMIND study group.
PMID: 42918626 [PubMed - indexed for MEDLINE]


Efficacy and Safety of Guselkumab in Patients with Crohn's Disease and Ulcerative Colitis: A Prospective Real-World Study.
Clin Gastroenterol Hepatol
Shafrir A, Choi D, Capucci LC, Hannett A, Tanouye J, Mathew AJ, Natt N, Dalal S, McDonald BD, Cleveland NK, Pekow J, Choden T, Cohen RD, Rubin DT.
PMID: 42913902 [PubMed - as supplied by publisher]


A real-world study of healthcare resource utilization and costs in patients with Crohn's disease and ulcerative colitis initiating ustekinumab treatment via Johnson & Johnson's BIOADVANCE program.
Crohns Colitis 360
Targownik L, Pone E, Latour MG, Boyerahmadi K, Yang H, Ling J, Tehrani A, Golden S, Marshall JK.
PMID: 42910390 [PubMed]


Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease.
Int J Colorectal Dis
de la Croix H, Åberg H, Fledsberg S, Park J, Bengtsson J, Hermanson M.
PMID: 42909622 [PubMed - indexed for MEDLINE]


Dual therapy with tofacitinib and steroids for acute severe ulcerative colitis: a randomized double-blind placebo-controlled trial.
J Crohns Colitis
Arora U, Verma M, Madan D, Singh M, Kandasamy D, Narang H, Goyal M, Mahajan M, Mundhra SK, Prasad S, Mubunnu M, Goyal A, Panwar R, Sehgal T, Dash NR, Sharma R, Bhardwaj V, Kedia S, Makharia G, Ahuja V.
PMID: 42909466 [PubMed - indexed for MEDLINE]


Pitfalls in the Diagnosis and Classification of Crohn's Disease: Misdiagnosis, Overdiagnosis, and Misclassification.
Turk J Gastroenterol
Bilican G, Brezina B, Sharip MT, Subramanian S, Mutlu A, Karakan T, Cindoruk M, Kalkan Ç, Noor NM.
PMID: 42909342 [PubMed - as supplied by publisher]


Comparative Effectiveness of Vedolizumab and Ustekinumab in Biologic-Experienced Ulcerative Colitis: A Real-World Multicenter Study from the Güntürk Group.
Turk J Gastroenterol
Araz F, Sezgin O, Barutçu S, Ünal NG, Bengi G, Öz, Karao, Dervi, Özer B, Akpinar H, Oruç N, Gi, Atay K, Kara B, Kasap E, Çekin AH, Yilmaz N, Altinta, Ate, Üçbilek E, Harput ZN, , Dolu S, Mammadov E, Odaba, Tuncel ET, Ku, Ta, Akbay Harmandar F, Seydao, Aykut BM, Kara T, Çapar H, Çetin DD, Atar GE, Püren Yücel S.
PMID: 42909316 [PubMed - as supplied by publisher]


Serum X-C Motif Chemokine Ligand 1 Is Associated with Endoscopic Activity in Crohn's Disease: A Clinical Biomarker Study.
Turk J Gastroenterol
Li Z, Hao Y, Chen J, Liu X, Xu W, Cheng Y.
PMID: 42909271 [PubMed - as supplied by publisher]


Engineering extracellular vesicles for inflammatory bowel disease and colitis-associated colorectal cancer: from therapeutic innovation to clinical translation.
Front Immunol
Huang M, Yuan J, Muro P, Jin T, Mao F, Zhu W.
PMID: 42909261 [PubMed - indexed for MEDLINE]


Multi-cohort meta-analysis, single-cell and Mendelian randomization analyses with experimental validation identify RHBDF2 as a shared mediator of ulcerative colitis and blood-brain barrier disruption.
Front Synaptic Neurosci
Cheng J, Xu A.
PMID: 42908994 [PubMed]


Efficacy and Safety of Risankizumab Among Patients With Ulcerative Colitis in East Asia: A Post Hoc Analysis of Two Randomized Clinical Trials.
J Gastroenterol Hepatol
Takeuchi K, Cao Q, Ozeki K, Kang SB, Chou JW, Mallick M, Matsuda T, Morisset PA, Kalabic J, D'Cunha R, Ogawa Y, Zhang Y, Duan WR, Yeh YY, Hisamatsu T.
PMID: 42908036 [PubMed - as supplied by publisher]


Shared decision making in inflammatory bowel disease: a qualitative study with patients, gastroenterologists, and nurses.
BMC Health Serv Res
Schoefs E, Michiels L, Straetemans N, Ferrante M, Verstockt B, Sabino J, Debrun L, Loddewijkx E, Van Audenhove C, Vermeire S, Huys I.
PMID: 42907825 [PubMed - indexed for MEDLINE]


Very early onset inflammatory bowel disease in Jordan: a single-center case series of clinical, genetic, and therapeutic features.
BMC Pediatr
Altamimi E, Almomani H, Alsmadi A, Issi N, Shurman M.
PMID: 42907806 [PubMed - indexed for MEDLINE]


Risk factors and prediction model of renal dysfunction in patients with inflammatory bowel disease: a retrospective cohort study.
BMC Gastroenterol
Zhou Y, Sun K, Chen X, Shen X, Chen J, Wang L, Chen C, Wang H, Wan Y, Yang L, Li L.
PMID: 42907758 [PubMed - indexed for MEDLINE]


Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update.
BMC Gastroenterol
Jiang J, Wojtowicz A, Uyei J, Jin H, Lindsley K, Sanchirico M.
PMID: 42907748 [PubMed - indexed for MEDLINE]


Is hemorrhoidal surgery really unsafe in inflammatory bowel disease? Results from the HEAD-IBD multicenter study on behalf of IG-IBD.
Tech Coloproctol
Felice C, Pugliese D, Gallo G, Di Tanna GL, Ascolani M, Sica GS, Bellato V, Franco M, Scaldaferri F, Parisio L, Colombo F, Bondurri A, Guerci C, Aratari A, Festa S, Ascari F, Savarino EV, Grossi U.
PMID: 42907681 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 59189    Page 1 of 2960  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1